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Abstract
Background: Two main genetic groups (B.12 and B.FTNF002-00) of Francisella tularensis ssp. holarctica are endemic
in Europe. The B.FTNF002-00 group proved to be dominant in Western European countries, while strains of the B.12
group were isolated mainly in Northern, Central and Eastern Europe. The clinical course of tularemia in the European
brown hare (Lepus europaeus) also shows distinct patterns according to the geographical area. Acute course of the
disease is observed in hares in Western European countries, while signs of sub-acute or chronic infection are more
frequently detected in the eastern part of the continent. The aim of the present study was to examine whether there
is any difference in the virulence of the strains belonging to the B.FTNF002-00 and B.12 genetic clades.
Results: Experimental infection of Fischer 344 rats was performed by intra-peritoneal injection of three dilutions of a
Hungarian (B.12 genotype) and an Italian (B.FTNF002-00 genotype) F. tularensis ssp. holarctica strain. Moderate
difference was observed in the virulence of the two genotypes. Significant differences were observed in total
weight loss values and scores of clinical signs between the two genotypes with more rats succumbing to
tularemia in groups infected with the B.FTNF002-00 genotype.
Conclusions: Results of the experimental infection are consistent with previous clinical observations and
pathological studies suggesting that F. tularensis ssp. holarctica genotype B.FTNF002-00 has higher pathogenic
potential than the B.12 genotype.
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Background
Francisella tularensis, the aetiological agent of tularemia
is a Gram-negative, zoonotic bacterium with a broad
host spectrum showing preference for infecting Lago-
morphs and Rodents. F. tularensis ssp. tularensis is en-
demic in North America and it has two subpopulations
(A.I -containing three major subgroups: A.I.3, A.I.8 and
A.I.12- and A.II), which differ in their geographic distribu-
tion, host and vector preference, virulence and genetic
characteristics [1, 2]. F. tularensis ssp. holarctica is moder-
ately virulent; it is endemic all over the Northern Hemi-
sphere, but despite its wide distribution, isolates within
this subspecies show little genetic diversity [1]. High reso-
lution molecular techniques (whole genome sequencing
with single-nucleotide polymorphism (SNP) detection)
differentiated two main genetic groups of F. tularensis ssp.
holarctica in Europe (B.12 and B.FTNF002-00) with
distinct geographic distribution [1]. The B.FTNF002-00
group proved to be dominant in Western European coun-
tries (France, Italy, the Netherlands, Spain), and the B.12
group was isolated mainly in Northern, Central and
Eastern Europe (Austria, Czech Republic, Finland,
Hungary, Norway, Romania, Slovakia, Sweden, Ukraine)
and the European part of Russia, while both genotypes were
detected in Germany and Switzerland [1, 3–11]. Whole
genome analysis of B.FTNF002-00 and B.12 genotypes
revealed distinct genetic differences (e.g. smaller overall
genome size of genotype B.FTNF002-00 compared to B.12;
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differences in gene sizes or orientations and the effects
of SNPs in protein coding) which may be the result of
a selection process acting on B.FTNF002-00 potentially
leading to enhanced virulence and replication potential
of this genotype [12]. Differences can be detected in
pathological signs of tularemia in European brown
hares (Lepus europaeus, the reservoir species of the
bacterium in Central Europe) in distinct geographical
regions in Europe. In Hungary (Eastern Europe), nec-
ropsy findings in hares generally include granuloma-
tous lesions in the lung, pericardium and kidneys due
to a sub-acute or chronic infection [13], while signs of
an acute clinical course (splenomegaly, congestion and
haemorrhagic lesions of organs) have been described in
hares that succumbed to tularemia in France and in the
Netherlands [14, 15]. Results of a recent publication con-
firmed that lesions observed in brown hares infected by F.
tularensis ssp. holarctica genotype B.12 differ from those
associated with the genotype B.FTNF002-00 in Switzerland
where both genotypes are present in nature [16].
The use of Fischer 344 rats was preferred in previous
experimental Francisella infections when feasibility of
vaccination or the host’s early innate immune response
were examined. Fischer 344 rats reflected best the hu-
man susceptibility to tularemia and showed higher re-
sistance to the pathogen compared to other laboratory
animals (e.g. mice) [17–20]. Difference in susceptibility
of Fischer 344 rats to F. tularensis ssp. tularensis wild
and reference (SCHU S4) strains, and F. tularensis ssp.
holarctica wild (strain from the B.12 clade) and live vaccine
(LVS) strains was also described earlier [18]. As intra-
peritoneal challenge was shown to be the most successful
route in experimental infections with Francisella spp., it is
considered to be an appropriate way to highlight differences
in the hosts’ susceptibility to tularemia or in the virulence
of bacterial strains [18, 21].
In this study the virulence of B.FTNF002-00 and B.12
F. tularensis ssp. holarctica genotypes was compared in
Fischer 344 rats performing experimental infection by
the intra-peritoneal route.
Methods
Bacterial strains
Genotype B.FTNF002-00 F. tularensis ssp. holarctica strain
was originally isolated in 2006 from a European brown
hare in Italy (strain ID: PV/21851/2006). Genotype B.12
was isolated in 2008 from a European brown hare in
Hungary (strain ID: FTH24/08). Strain PV/21851/2006 was
subcultured three times before the experiments, while
strain FTH24/08 was gained after a mouse passage and
three subcultures. Bacterial strains were cultured on modi-
fied Francis agar (chocolate agar supplemented with 1%
glucose and 0.1% cysteine) for 48 h at 37 °C and 5% CO2.
Colonies from these cultures were first suspended in sterile
saline and adjusted to 0.5 McFarland turbidity. Subse-
quently 100 μl of each dilution from a tenfold dilution
series of the previous suspension was inoculated on modi-
fied Francis agar and incubated for 48 h to determine the
number of colony forming units (CFU; 4 × 107). For the in-
fection of the Fischer 344 rats, fresh bacterial colonies were
suspended in sterile saline and adjusted to 0.5 McFarland
turbidity, and then diluted in sterile saline to obtain 100,
101 and 102 CFU suspensions. Following the experimental
infection of the rats, CFUs were checked from the used di-
lutions on modified Francis plates after 48 h of incubation.
Experimental infection
Age matched (7 weeks) female Fischer 344 rats (Charles
River Laboratories Inc., Wilmington, MA, USA) were
used in the study. The animals were kept in accordance
with all national and institutional regulations. The ani-
mal experiment was performed according to the guide-
lines approved by the National Ethical Committee
(permit number: PEI/001/1927-4/2015) and the ethical
committee of the Institute for Veterinary Medical Re-
search. The rats (6 animals/group) were injected via the
intra-peritoneal route with 100 μl inocula containing ei-
ther 100, 101 and 102 CFUs of the B.FTNF002-00 or
B.12 genotypes of F. tularensis ssp. holarctica. A group
of 6 Fischer 344 rats injected intra-peritoneally with 100
μl sterile saline was used as a negative control in the ex-
periment. After infection, the animals were checked and
measured at 24 h intervals by the same person for 21
days. Clinical signs were registered throughout the ex-
periment and they were used to establish three categor-
ies (mild, moderate and severe) of disease severity to be
used in the analyses (Table 1). Rats that did not succumb
to the infection were euthanized by CO2 overexposure
at the end of the experiment. Slide agglutination test
was performed at necropsy with heart blood, using the
commercially available F. tularensis antigen (Bioveta,
a.s., Ivanovicena Hané, Czech Republic). After a gross
pathological examination, tissue samples were collected
from the lungs, thymus, liver, spleen, kidneys, small and
large intestine, muscle, bone marrow and brain (cerebrum
Table 1 Categories of clinical signs shown by Francisella tularensis
ssp. holarctica infected Fischer 344 rats
Severity of disease Clinical signs
Mild weight loss, accumulation of porphyrin around
the eyes (one or both sides), nasal discharge
Moderate weight loss, marked porphyrin secretion around
the eyes (one or both sides), nasal discharge,
ruffled fur, decreased activity, diarrhoea
Severe weight loss, marked porphyrin secretion around
the eyes (both sides), nasal discharge, ruffled fur,
inactivity, diarrhoea, laboured breathing, weakness
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and cerebellum), fixed in 8% neutral buffered formalin
and submitted for histological and immunohistochemical
examinations.
Histology and immunohistochemistry
Pathological changes were studied by light microscopy
on four-micrometer thick sections of formalin-fixed,
paraffin-embedded tissue samples stained with haema-
toxylin and eosin. Immunohistochemical examinations
were performed as described before [22]. In brief, sec-
tions were de-paraffinized and incubated in 3% H2O2
solution for 10 min and in 2% solution of skimmed milk
powder for 20 min. The sections were incubated over-
night at 4 °C with anti-F. tularensis hyperimmune rabbit
serum diluted 1:30,000 in phosphate-buffered saline
(PBS). Antibody binding was detected using anti-rabbit
antibodies with horse-radish peroxidase (HRP)-labelled
polymer following manufacturer’s instructions (EnVi-
sionTM + Kit; Dako, Denmark). Non-infected rat tissue
samples served as a negative control. For some sections
antiserum was replaced by PBS to rule out the possibility
of any nonspecific binding. Lesions and immunoreactiv-
ity were evaluated by a single pathologist in a treatment-
blinded manner. The amount of antigen in the lung,
liver and spleen was graded based on the number of af-
fected organs and antigen observations/field of vision at
100x magnification (scored as minimal: <10 observations
in only one organ; low: <10 observations in two or three
organs; moderate: 10–20 observations in two or three
organs; high: >20 observations in all three organs).
Fig. 1 Comparison of changes in body weight in Francisella tularensis ssp. holarctica infected Fischer 344 rats. Fischer 344 rats were infected with
three concentrations of F. tularensis ssp. holarctica genotype B.12 (red) or B.FTNF002-00 (purple). Challenge doses are given under each diagram in
colony forming units. Values are representing the percent change in body weight between days 3 and 13 post infection relative to the initial weight
on the day of infection for each animal. Positive values representing weight gain, while negative values are showing weight loss. Asterisks are
representing the death of the animals
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Statistical analysis
The results of the experimental infection experiments
were compared with independent t-test, Mann-Whitney
U test and Kruskal-Wallis test in Statistica software
(Dell Software, Version 13.1., Aliso Viejo: Dell Inc., CA,
USA). The virulence of the B.FTNF002-00 and B.12
groups was compared based on the statistical analyses
of the total weight loss and severity of clinical signs
(graded as none = 0, mild = 1, moderate = 2 and severe
= 3). Total weight loss represents the percent change in
body weight on the day when the smallest weight was
measured (minimum weight) relative to the weight of
Table 2 Clinical and post mortem data of Fischer 344 rats (6 rats/groups) infected with Francisella tularensis ssp. holarctica
Strain Infectious dose Clinical signa Total weight loss (%) Day of deathb Seroconversion Amount of antigen (IHC)c
B.12 100 CFU mild 0 E + low
0 E + minimal
2.5 E + none
3.5 E + none
severe 7.3 E + low
24 10 - high
101 CFU mild 0 E + minimal
0 E + low
3 E + minimal
10.6 E + minimal
moderate 3.6 E + minimal
severe 18.1 8 - high
102 CFU mild 0 E + minimal
3.7 E + none
7 E + minimal
17.6 E + minimal
moderate 4.6 E + low
13.6 E + minimal
B.FTNF002-00 100 CFU mild 0 E + none
3.1 E + none
14.4 E + minimal
severe 5.6 7 - high
11.4 8 - high
35.5 12 - high
101 CFU mild 5.7 E + none
11.4 E + none
moderate 9 E + low
severe 12.4 7 - moderate
16.5 E + low
21.5 9 - moderate
102 CFU mild 4.8 E + none
6.3 E + none
moderate 7.7 E + minimal
9.3 E + low
19.3 E + none
severe 12.3 4 - high
aThe most severe clinical sign shown during the experiment
bDay of death after injection; E: euthanized on day 21 post infection
cDuring the immunohistochemical examinations the amount of antigen was evaluated in the lung, liver and spleen and was based on the number of affected
organs and antigen observations/field of vision at 100× magnification
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the day of infection (initial weight) for each animal
(Additional file 1). Clinical sign scores recorded be-
tween days 1 and 13 post infection were compared be-
tween groups infected with the two genotypes using
Mann-Whitney U test (Additional file 1).
Results
All rats showed clinical signs between days 3–12
post infection after intra-peritoneal inoculation with
suspensions containing either 100, 101 and 102 CFUs
of F. tularensis ssp. holarctica strains (both genotypes
B.12 and B.FTNF002-00). Clinical signs included por-
phyrin accumulation around the eyes, nasal discharge,
weight loss, weakness, ruffled fur, inactivity, diarrhoea
and laboured breathing (Table 1). General linear model
analysis showed the effect of the challenge dose on the
course of the disease (timing of the most severe symp-
toms), however, association between the severity of the
clinical signs and the challenge dose was not detected.
More than 50% of the rats survived the intra-peritoneal
challenge by F. tularensis ssp. holarctica strains in all
but one group (genotype B.FTNF002-00, 100 CFU),
thus further analysis was based on the comparison of
the two main groups differing in the genotype of the in-
fectious agent. Total weight loss was significantly
higher (p = 0.0348; independent t-test) in the group in-
fected with the B.FTNF002-00 genotype. Changes in
body weight (%) between days 3 and 13 post infection
are shown in Fig. 1, and the percentages of the total
weight loss are listed in Table 2. Comparison of the
severity of clinical signs (based on clinical scores be-
tween days 1–13 post infection) revealed significant
differences (p = 0.004; Mann-Whitney U test) between
the two groups. Median values of the clinical scores
and changes in weight loss between days 1 and 13 post
infection are demonstrated in Fig. 2. The median values
of the clinical scores between days 1–13 post infection
showed, that rats infected with the B.12 genotype
recovered from the disease two days earlier than rats
infected with genotype B.FTNF002-00. In the B.FTNF002-
00 genotype infected groups 33.3% (6/18) of the animals
succumbed to tularemia between days 4–12 post in-
fection. In contrast, only 11.1% (2/18) of the rats died
of the disease caused by the B.12 genotype on days 8
and 10 post infection. Post mortem examinations did
not reveal differences in the pathological changes as-
sociated with the two bacterial strains. At necropsy,
the deceased rats were seronegative while all surviv-
ing rats showed seroconversion in slide agglutination
test on day 21 post infection (Table 2). Macroscopic
pathological findings were scarce, an enlarged spleen
being occasionally observed in both deceased and eu-
thanized rats. Histological findings in rats that suc-
cumbed to the infection consisted of acute multiple
necrotic foci in the liver and spleen and immunohisto-
chemistry showed large amounts of antigen in these
organs (Fig. 3). Sub-acute interstitial lympho-histiocytic
inflammation was also observed in the lung with high
or moderate amounts of antigen in rats that died of the
infection. Seropositive rats which were sacrificed on
day 21 post infection showed distended sinusoids and
activation of Kupffer cells associated with multifocal
interstitial infiltration by mixed inflammatory cells in
the liver and a moderate follicular hyperplasia and
hyperaemia in the spleen with no or low amounts of
antigen (Table 2).
Discussion
While clear differences are described in the virulence of
the F. tularensis ssp. tularensis subpopulations, little or
no information is available about the virulence of the
subpopulations of the widespread holarctica subspecies
[23]. Interactions among hosts with different susceptibil-
ity to tularemia and strains of the two genetic groups of
F. tularensis ssp. holarctica (B.12 and FTNF002-00) were
previously compared in vitro, but no difference was
detected in the ability of genotypes to evade the hosts’
complement system [24].
The susceptibility of Fischer 344 rats to tularemia was
described in previous examinations [17, 19, 20]. Experi-
mental infection of Fischer 344 rats with intra-peritoneal
inoculation of 101 CFU of a F. tularensis ssp. holarctica
strain from Sweden (B.12 genotype) induced fatal disease
within 10 days [18].
The results of the current study revealed moderate
difference in the pathogenic potential of the two strains
belonging to the two genetic groups of F. tularensis ssp.
holarctica and support the hypothesis that B.FTNF002-
Fig. 2 Median values of changes in body weight and clinical sign scores
in experimentally infected rats. Fischer 344 rats were infected with
Francisella tularensis ssp. holarctica genotype B.12 or B.FTNF002-00.
Values are representing the median of the clinical sign scores (dashed
lines) and the median percentages of body weight changes (solid lines)
between days 1 and 13 post infection related to the groups infected
with B.12 (red) or B.FTNF002-00 (purple) genotypes
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00 genotype is more virulent than the B.12 genotype.
Low mortality rates were observed in the infected ani-
mals, which might be an effect of a possible attenuation
process during the culture of bacteria on artificial media
and implies the potential need for the use of higher bac-
terial loads in experimental infections. However, clinical
signs manifested in all rats, and they were in accordance
with previously described symptoms in Fischer 344 rats
infected subcutaneously with F. tularensis ssp. tularensis
SCHU S4 strain [19]. Interestingly, the challenge dose
did not affect the severity of clinical signs, the time and
number of deaths, nor the extent of weight loss, simi-
larly to the observations in previous studies on non-
human primates and Fischer 344 rats [19, 25]. Analysis
of weight loss was used for the determination of suscep-
tibility of Fischer 344 rats to tularemia before [19]. In
the current experiment rats infected with B.FTNF002-00
genotype showed significantly higher total weight loss
and more prolonged course of the disease compared to
rats infected with B.12 genotype (Figs. 1 and 2), suggest-
ing a more severe progression of the illness during infec-
tion with the B.FTNF002-00 genotype. The assumed
higher virulence of B.FTNF002-00 genotype is consistent
with previous observations on the clinical features and
pathology of tularemic brown hares associated with the
two genotypes. Nevertheless, experimental infection of
the brown hare, the host presenting different types of
pathological changes, with a higher number of strains
belonging to these two genotypes should confirm field
observations and enable deeper insight into the assumed
difference in virulence between genotypes. Examining the
F. tularensis ssp. holarctica susceptibility of European
brown hares originating from distinct geographical areas
may also provide important additional information about
the ecology of this pathogen.
Conclusion
The moderate differences in the pathogenic potential of
B.12 and B.FTNF002-00 genotype F. tularensis ssp.
holarctica strains, as observed during the experimental
infection of Fischer 344 rats support a higher virulence
of B.FTNF002-00, which is the dominant genotype in
Western European countries. The results are in accord-
ance with previous observations on the pathology of tu-
laremic brown hares infected by the two genotypes.
Additional file
Additional file 1: Weight data and clinical sign scores of Francisella
tularensis ssp. holarctica infected Fischer 344 rats. The animals were
infected with the B.12 or the B.FTNF002-00 genotype (genotype of
infectious agent) with either 100, 101 and 102 CFUs of the bacteria
suspensions (infectious dose). Weight data (in grams) on the day of
infection (initial weight) and between days 1–13 post infection (pi.)
with the clinical sign scores (graded as none = 0, mild = 1, moderate = 2
and severe = 3; 3* = the animal succumbed to the infection) are provided
for all rats. (XLSX 14 kb)
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CFU: Colony forming units; HRP: Horse-radish peroxidase; LVS: Live vaccine
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Fig. 3 Histological picture of the spleen of a Francisella tularensis ssp. holarctica genotype B.FTNF002-00 infected Fischer 344 rat. Typical necrotic
foci (hematoxilin-eosin, left) and the accumulation of F. tularensis antigen primarily at the edges of the necrotic area (immunohistochemistry, right).
Bar = 50 μm
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